Bioceres Crop Solutions (BIOX) Q4 FY26 earnings call

Bioceres Crop Solutions faced a challenging FY26 marked by litigation and a seed business reconfiguration, leading to an 18% revenue decline. However, Q4 showed stabilization with broadly flat revenues and a return to positive adjusted EBITDA, driven by significant cost reductions. The company is now focused on portfolio rationalization, operational efficiencies, and addressing its capital structure, targeting improved gross margins and reduced SG&A in the coming fiscal years.